As of August 28, 2026, Anebulo Pharmaceuticals, Inc. (ANEB) has a DilutionWatch DilutionScore of 49/100, rated MEDIUM dilution risk. Anebulo Pharmaceuticals, Inc. has a market capitalization of $19.17M, 40.78M shares outstanding, 2 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split
model est. 55%
• 50-day avg $0.60 below $1 exchange minimum
Market Data
Market Cap$19.17M
Shares Outstanding40.78M
Float24.13M
Cash$9.04M
DebtN/A
Short InterestN/A
Institutional Holdings
QoQ: ↓ 96.4% shares (2026Q1 vs prior)
2 institutional holders · 799.2K shares
#1
MORGAN STANLEY
798.8K shares
#2
BARCLAYS PLC
399 shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest5.6K
Days to Cover6.2
% of Float0.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track ANEB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANEB — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required